
### [MONDO:0015157](http://purl.obolibrary.org/obo/MONDO_0015157)
**Label:** human herpesvirus 8-related disorder

**Subclasses:** [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), 

**Corr. equiv. classes:** [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160), [Orphanet:93686](http://www.orpha.net/ORDO/Orphanet_93686), [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), 

**Class expressions from DL-Learner:**

- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200035](http://purl.obolibrary.org/obo/HP_0200035) (Skin plaque) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0100742](http://purl.obolibrary.org/obo/HP_0100742) (Vascular neoplasm) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 62.50%
- [HP:0008940](http://purl.obolibrary.org/obo/HP_0008940) (Generalized lymphadenopathy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 62.50%


